المؤلفون: Johann Bauersachs, Rudolf A. de Boer, JoAnn Lindenfeld, Biykem Bozkurt

المساهمون: Cardiovascular Centre (CVC)

المصدر: European Heart Journal, 43(5), 367-376. Oxford University Press

مصطلحات موضوعية: Artificial intelligence, Epidemiology, DAPAGLIFLOZIN, Heart failure, Activators of soluble guanylate cyclase, Imaging, Angiotensin Receptor Antagonists, DOUBLE-BLIND, QUALITY-OF-LIFE, Humans, Angiotensin receptor-neprilysin inhibitors, RISK, SACUBITRIL/VALSARTAN, OUTCOMES, SARS-CoV-2, Aminobutyrates, Biphenyl Compounds, EMPAGLIFLOZIN, COVID-19, Stroke Volume, Pharmacotherapy, Device therapy, SGLT-2 inhibitor, Cardiomyopathies, Cardiology and Cardiovascular Medicine, INHIBITORS, REDUCED EJECTION FRACTION, Biomarkers

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d3c9acd9c3f6b0dfa4597b4b432c3cdTest
https://research.rug.nl/en/publications/6d9e3f2c-e080-4381-9704-c1d9b1863790Test

المؤلفون: Arne Gessner, Anna Gemeinhardt, Agnes Bosch, Dennis Kannenkeril, Christian Staerk, Andreas Mayr, Martin F. Fromm, Roland E. Schmieder, Renke Maas

المصدر: Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-11 (2022)
Cardiovascular Diabetology

مصطلحات موضوعية: Blood Glucose, Male, Time Factors, Endocrinology, Diabetes and Metabolism, Empagliflozin, Arginine, Double-Blind Method, Glucosides, Predictive Value of Tests, SDMA, Type 2 diabetes mellitus, Humans, Diseases of the circulatory (Cardiovascular) system, Prospective Studies, ddc:610, Benzhydryl Compounds, Sodium-Glucose Transporter 2 Inhibitors, Original Investigation, Glycated Hemoglobin, Cross-Over Studies, Middle Aged, Dapagliflozin, Cardiovascular disease, Homoarginine, ADMA, Treatment Outcome, Diabetes Mellitus, Type 2, RC666-701, SGLT-2 inhibitor, Female, Cardiology and Cardiovascular Medicine, Biomarkers

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37197d9cf450acaf117361c0c553c9b4Test
https://doaj.org/article/84d0ad9359a24a469e3fdccbc5dcb7eaTest

المؤلفون: Jan Biegus, Adriaan A Voors, Sean P Collins, Mikhail N Kosiborod, John R Teerlink, Christiane E Angermann, Jasper Tromp, Joao Pedro Ferreira, Michael E Nassif, Mitchell A Psotka, Martina Brueckmann, Afshin Salsali, Jonathan P Blatchford, Piotr Ponikowski

المساهمون: Cardiovascular Centre (CVC)

المصدر: European Heart Journal, 44(1):ehac530. Oxford University Press

مصطلحات موضوعية: WIN RATIO, SGLT-2 inhibitor, Decongestion, Empagliflozin, Acute heart failure, Cardiology and Cardiovascular Medicine, DIURETIC RESPONSE, CONGESTION

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9b5eb3fcb083d44ed2be9823ad28240Test
https://pubmed.ncbi.nlm.nih.gov/36426405Test

المؤلفون: Dario Giugliano, Miriam Longo, Lorenzo Scappaticcio, Giuseppe Bellastella, Maria Ida Maiorino, Katherine Esposito

المساهمون: Giugliano, D., Longo, M., Scappaticcio, L., Bellastella, G., Maiorino, M. I., Esposito, K.

المصدر: Cardiovascular Diabetology
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-11 (2021)

مصطلحات موضوعية: Male, Kidney Disease, Time Factors, Time Factor, Heart Diseases, Endocrinology, Diabetes and Metabolism, Risk Assessment, Type 2 diabete, Cardiovascular outcome trials, Diseases of the circulatory (Cardiovascular) system, Humans, Sodium-Glucose Transporter 2 Inhibitors, Original Investigation, Aged, Clinical Trials as Topic, Sodium-Glucose Transporter 2 Inhibitor, Cardiorenal outcomes, SGLT-2 inhibitors, Cardiorenal outcome, Type 2 diabetes, Heart Disease Risk Factor, Middle Aged, Cardiovascular outcome trial, Heart Disease, Treatment Outcome, Diabetes Mellitus, Type 2, Heart Disease Risk Factors, RC666-701, SGLT-2 inhibitor, Female, Kidney Diseases, Cardiology and Cardiovascular Medicine, Human

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74ee06316808c9b8baa3d3f2ed4cdb48Test
http://europepmc.org/articles/PMC8680308Test

المؤلفون: Giaccari, Andrea, Pontremoli, R., Perrone Filardi, P.

المساهمون: Giaccari, A., Pontremoli, R., Perrone Filardi, P.

المصدر: International journal of cardiology. 351

مصطلحات موضوعية: Heart Failure, Multidisciplinary, Hypoglycemic Agent, Risk Factor, SGLT-2 inhibitors, Type 2 diabetes, Settore MED/13 - ENDOCRINOLOGIA, Type 2 diabete, Management, Diabetes Mellitus, Type 2, Risk Factors, SGLT-2 inhibitor, Diabetes Mellitus, Humans, Hypoglycemic Agents, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic, Cardiology and Cardiovascular Medicine, Sodium-Glucose Transporter 2 Inhibitors, Type 2, Human

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8caea76f35b7f9cf39dd34c3875115a4Test
https://pubmed.ncbi.nlm.nih.gov/35134445Test

المؤلفون: Miriam Longo, Lorenzo Scappaticcio, Paola Caruso, Katherine Esposito, Dario Giugliano

المساهمون: Giugliano, D., Longo, M., Scappaticcio, L., Caruso, P., Esposito, K.

المصدر: Cardiovascular Diabetology
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-10 (2021)

مصطلحات موضوعية: Blood Glucose, medicine.medical_specialty, lcsh:Diseases of the circulatory (Cardiovascular) system, Diabetic Cardiomyopathies, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Heart failure, Type 2 diabetes, Glycemic Control, Review, MACE, Risk Assessment, Class effect, Age, Primary and secondary prevention, Risk Factors, Diabetes mellitus, Internal medicine, medicine, Secondary Prevention, Humans, Diabetic Nephropathies, Myocardial infarction, Diabetic kidney disease, Stroke, Sodium-Glucose Transporter 2 Inhibitors, Glycated Hemoglobin, business.industry, SGLT-2 inhibitors, medicine.disease, Natural history, Primary Prevention, Treatment Outcome, Amputation, Diabetes Mellitus, Type 2, lcsh:RC666-701, SGLT-2 inhibitor, Cardiology and Cardiovascular Medicine, business, Biomarkers, Kidney disease

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4e08392f4727a6bdf54c7955d52abfdTest
http://hdl.handle.net/11591/443919Test

المؤلفون: Lorenzo Scappaticcio, Dario Giugliano, Miriam Longo, Katherine Esposito, Giuseppe Bellastella

المساهمون: Giugliano, D., Scappaticcio, L., Longo, M., Bellastella, G., Esposito, K.

المصدر: Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-5 (2021)
Cardiovascular Diabetology

مصطلحات موضوعية: medicine.medical_specialty, endocrine system, Kidney Disease, GLP-1 receptor agonist, Endocrinology, Diabetes and Metabolism, Type 2 diabetes, Incretins, Risk Assessment, Type 2 diabete, Glucagon-Like Peptide-1 Receptor, Risk Factors, Diabetes mellitus, Internal medicine, Cardiovascular Disease, Risk of mortality, medicine, Humans, Diseases of the circulatory (Cardiovascular) system, Sodium-Glucose Transporter 2 Inhibitors, Stroke, Glucagon-like peptide 1 receptor, Protective Factor, Cause of death, GLP-1 receptor agonists, business.industry, Risk Factor, Sodium-Glucose Transporter 2 Inhibitor, SGLT-2 inhibitors, Protective Factors, Incretin, medicine.disease, Hospitalization, Cardiorenal benefits, Cardiorenal benefit, Treatment Outcome, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Heart failure, RC666-701, SGLT-2 inhibitor, Commentary, Kidney Diseases, Cardiology and Cardiovascular Medicine, business, Mace, Human

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a16c3bf36067332f81bbe531ea8ea647Test
http://hdl.handle.net/11591/467157Test

المؤلفون: Oliver Schnell, Michael A. Nauck, Hiddo J.L. Heerspink, Xavier Cos, Baruch Itzhak, Eberhard Standl, Nebojsa Lalic, Antonio Ceriello

المساهمون: Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET), Groningen Kidney Center (GKC)

المصدر: Cardiovascular Diabetology, 19(1):47. BioMed Central Ltd.
Cardiovascular Diabetology
Cardiovascular Diabetology, Vol 19, Iss 1, Pp 1-10 (2020)

مصطلحات موضوعية: medicine.medical_specialty, lcsh:Diseases of the circulatory (Cardiovascular) system, Diabetic ketoacidosis, GLP-1 receptor agonist, Endocrinology, Diabetes and Metabolism, PIONEER-6, MEDLINE, Disease, DISEASE, End stage renal disease, CVOT, Diabetes management, Internal medicine, Diabetes mellitus, medicine, CREDENCE, geography, Summit, geography.geographical_feature_category, business.industry, Semaglutide, MORTALITY, Diabetes, CAROLINA, medicine.disease, Cardiovascular risk, lcsh:RC666-701, Family medicine, SGLT-2 inhibitor, Commentary, Cardiology and Cardiovascular Medicine, business, REWIND, DAPA-HF

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc601b0c55f1ab2c814bdb6efb37d267Test
https://doi.org/10.1186/s12933-020-01022-7Test

المؤلفون: Dario Giugliano, Antonio Ceriello, Maria Ida Maiorino, Katherine Esposito, Giuseppe Bellastella, Paolo Chiodini, Carlo Garofalo, Luca De Nicola

المساهمون: Giugliano, D., De Nicola, L., Maiorino, M. I., Bellastella, G., Garofalo, C., Chiodini, P., Ceriello, A., Esposito, K.

المصدر: Cardiovascular Diabetology, Vol 19, Iss 1, Pp 1-6 (2020)
Cardiovascular Diabetology

مصطلحات موضوعية: lcsh:Diseases of the circulatory (Cardiovascular) system, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, MACE, Type 2 diabetes, Kidney, Risk Assessment, Diabetic nephropathy, Efficacy, Risk Factors, Internal medicine, Diabetes mellitus, Humans, Medicine, Diabetic Nephropathies, cardiovascular diseases, Renal Insufficiency, Chronic, Diabetic kidney disease, Adverse effect, Sodium-Glucose Transporter 2 Inhibitors, Clinical Trials as Topic, business.industry, SGLT-2 inhibitors, Protective Factors, medicine.disease, Statin therapy, Treatment Outcome, Diabetes Mellitus, Type 2, Cardiovascular Diseases, lcsh:RC666-701, SGLT-2 inhibitor, Commentary, Albuminuria, Hydroxymethylglutaryl-CoA Reductase Inhibitors, medicine.symptom, Cardiology and Cardiovascular Medicine, business, Mace, Kidney disease

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94a142efb96be5ee5f9ae62d2c9a5cc3Test
https://doi.org/10.1186/s12933-020-01010-xTest

المؤلفون: Yoshifusa Aizawa, Sho Yuasa, Masaaki Okabe, Yoshio Ikeda, Satoshi Fujita, Takao Sato

المصدر: Journal of Atherosclerosis and Thrombosis

مصطلحات موضوعية: Male, medicine.medical_specialty, Coronary Artery Disease, 030204 cardiovascular system & hematology, Nerve conduction velocity, law.invention, Coronary artery disease, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Randomized controlled trial, Glucosides, Left atrial, law, Internal medicine, Epicardial adipose tissue, Internal Medicine, medicine, Humans, Dapagliflozin, Benzhydryl Compounds, P-wave indices, Sodium-Glucose Transporter 2 Inhibitors, Aged, business.industry, Biochemistry (medical), Atrial fibrillation, Middle Aged, medicine.disease, Volume (thermodynamics), chemistry, Adipose Tissue, Diabetes Mellitus, Type 2, SGLT-2 inhibitor, Cardiology, Female, Original Article, Cardiology and Cardiovascular Medicine, business, Pericardium, 030217 neurology & neurosurgery

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85157584028fd0a34388a5f5ca3cd667Test
https://pubmed.ncbi.nlm.nih.gov/32115470Test